Skip to content

EBIT at other companies

Repligen logo
RepligenRGEN
$15.94M+142%
ADMA Biologics logo
ADMA BiologicsADMA
$58.27M+67.1%
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
Danaher logo
DanaherDHR
Revvity logo
RevvityRVTY
TEC
Bio-TechneTECH

Other financials

Income statement

See full
Revenue$65.8M+40.5%
Gross profit$33.7M+336%
Operating income-$2.2M+95.6%
Net income-$3.7M+87.5%
EPS (diluted)-$0.02+90.5%

Balance sheet

See full
Cash & equivalents$165.9M-41.8%
Total debt$270.9M-17.1%
Total equity$211.6M-29.6%
Total assets$713.2M-25.7%

Cash flow

See full
Operating cash flow$8.7M+192%
CapEx$4.4M-1.4%
Free cash flow$4.2M+130%

Valuation

See full
Market cap$849.64M+204%
Enterprise value$954.59M+198%
P/S4.2×+3.0×

Profitability

See full
Gross margin29.3%-8.0pp
Operating margin-82.2%-16.6pp
Net margin-51.1%-9.9pp
FCF margin-25.7%

Returns & leverage

See full
Return on equity-40.8%-4.0pp
Debt / equity1.3×+0.2×
Current ratio5.9×-0.1×

Where this comes from

Calculated from Maravai LifeSciences Holdings, Inc.’s reported figures.

The official record: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Maravai LifeSciences Holdings, Inc.'s ebit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Maravai LifeSciences Holdings, Inc.'s EBIT?
Maravai LifeSciences Holdings, Inc. (MRVI) reported EBIT of -$2.16M in Q1 2026.
How has Maravai LifeSciences Holdings, Inc.'s EBIT changed year-over-year?
Maravai LifeSciences Holdings, Inc.'s EBIT increased by 95.6% year-over-year, from -$49.16M to -$2.16M.
What is the long-term trend for Maravai LifeSciences Holdings, Inc.'s EBIT?
Over 4 years (2021 to 2025), Maravai LifeSciences Holdings, Inc.'s EBIT has grown at a -21.1% compound annual growth rate (CAGR), from $554.65M to -$215.27M.
What does EBIT mean?
Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.